Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Journal of Atherosclerosis and Thrombosis
|
December 2, 2016
Professor Philip Yu-An Ding 1949-2015
Philip Barter, Edward Janus, Yuji Matsuzawa, et al.
European Heart Journal
|
May 4, 2004
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
David Colquhoun, Anthony Keech, David Hunt, et al.
Current Medical Research and Opinion
|
March 31, 2011
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)
Stephen J Nicholls, Marilyn Borgman, Steven E Nissen, et al.
Diabetes Care
|
May 30, 2006
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study
James Shepherd, Philip Barter, Rafael Carmena, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 29, 2007
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia
Philip Barter, Y Ruth McPherson, Kijoung Song, et al.
Journal of the American College of Cardiology
|
April 2, 2011
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials
David D Waters, Jennifer E Ho, David A DeMicco, et al.
Heart, Lung & Circulation
|
December 20, 2005
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005
Andrew Tonkin, Philip Barter, James Best, et al.
Circulation
|
September 11, 2013
Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges
Robert S Rosenson, H Bryan Brewer, Benjamin Ansell, et al.
The New England Journal of Medicine
|
September 28, 2007
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter, Antonio M Gotto, John C LaRosa, et al.
Nature Reviews. Cardiology
|
September 2, 2015
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S Rosenson, H Bryan Brewer, Benjamin J Ansell, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Journal of Atherosclerosis and Thrombosis
|
December 2, 2016
Professor Philip Yu-An Ding 1949-2015
Philip Barter, Edward Janus, Yuji Matsuzawa, et al.
European Heart Journal
|
May 4, 2004
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
David Colquhoun, Anthony Keech, David Hunt, et al.
Current Medical Research and Opinion
|
March 31, 2011
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN)
Stephen J Nicholls, Marilyn Borgman, Steven E Nissen, et al.
Diabetes Care
|
May 30, 2006
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study
James Shepherd, Philip Barter, Rafael Carmena, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 29, 2007
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia
Philip Barter, Y Ruth McPherson, Kijoung Song, et al.
Journal of the American College of Cardiology
|
April 2, 2011
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials
David D Waters, Jennifer E Ho, David A DeMicco, et al.
Heart, Lung & Circulation
|
December 20, 2005
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005
Andrew Tonkin, Philip Barter, James Best, et al.
Circulation
|
September 11, 2013
Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges
Robert S Rosenson, H Bryan Brewer, Benjamin Ansell, et al.
The New England Journal of Medicine
|
September 28, 2007
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter, Antonio M Gotto, John C LaRosa, et al.
Nature Reviews. Cardiology
|
September 2, 2015
Dysfunctional HDL and atherosclerotic cardiovascular disease
Robert S Rosenson, H Bryan Brewer, Benjamin J Ansell, et al.
Page
of 8